ADAR1 Capital Invests $40 Million in Beam Therapeutics
On May 15, 2026, ADAR1 Capital Management disclosed a new position in Beam Therapeutics (BEAM), acquiring approximately 1.45 million shares valued at an estimated $40.13 million based on quarterly average pricing.
Tickers: $BEAM